Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

13.04.2022 | main topic

Sarcopenia—a geriatric pandemic

A narrative review

verfasst von: Marcus Köller

Erschienen in: Wiener Medizinische Wochenschrift

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

With growing life expectancy, the prevalence of frailty and sarcopenia will continuously increase during the next decades. Geographical differences have been described, and depending on the population studied, sarcopenia is evident in 10% of community-dwelling people, increasing up to 40 to 50% among those living in nursing homes. Sarcopenia is a complex age-related process of multifactorial pathogenesis, influenced by lifestyle, nutrition, biological processes during aging, and also immunological and endocrine mechanisms. For diagnostic criteria, physical parameters (muscle mass measurement) and functional aspects (muscle strength, gait speed, physical performance) are required. In routine clinical care, screening patients using the SARC‑F questionnaire is recommended by recent guidelines of the European Workgroup for Sarcopenia.

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Literatur
1.
Zurück zum Zitat Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M56. CrossRefPubMed Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M56. CrossRefPubMed
2.
Zurück zum Zitat Bruyère O, Beaudart C, Ethgen O, Reginster JY, Locquet M. The health economics burden of sarcopenia: a systematic review. Maturitas. 2019;119:61–9. CrossRefPubMed Bruyère O, Beaudart C, Ethgen O, Reginster JY, Locquet M. The health economics burden of sarcopenia: a systematic review. Maturitas. 2019;119:61–9. CrossRefPubMed
3.
Zurück zum Zitat Cesari M, Calvani R, Marzetti E. Frailty in Older Persons. Clin Geriatr Med. 2017;33:293–303. CrossRefPubMed Cesari M, Calvani R, Marzetti E. Frailty in Older Persons. Clin Geriatr Med. 2017;33:293–303. CrossRefPubMed
5.
Zurück zum Zitat Tzankoff SP, Norris AH. Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:1001–6. PubMed Tzankoff SP, Norris AH. Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:1001–6. PubMed
6.
Zurück zum Zitat Chumlea WC, Guo SS, Vellas B, Guigoz Y. Techniques of assessing muscle mass and function (sarcopenia) for epidemiological studies of the elderly. J Gerontol A Biol Sci Med Sci. 1995;50(Spec No):45–51. PubMed Chumlea WC, Guo SS, Vellas B, Guigoz Y. Techniques of assessing muscle mass and function (sarcopenia) for epidemiological studies of the elderly. J Gerontol A Biol Sci Med Sci. 1995;50(Spec No):45–51. PubMed
7.
9.
Zurück zum Zitat Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016;17:675–7. CrossRefPubMed Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016;17:675–7. CrossRefPubMed
10.
Zurück zum Zitat Falcon LJ, Harris-Love MO. Sarcopenia and the new ICD-10-CM code: screening, staging, and diagnosis considerations. Fed Pract. 2017;34:24–32. PubMedPubMedCentral Falcon LJ, Harris-Love MO. Sarcopenia and the new ICD-10-CM code: screening, staging, and diagnosis considerations. Fed Pract. 2017;34:24–32. PubMedPubMedCentral
12.
Zurück zum Zitat Jang EH, Han YJ, Jang SE, Lee S. Association between diet quality and Sarcopenia in older adults: systematic review of prospective cohort studies. Life. 2021;11(8):811–28. CrossRefPubMedPubMedCentral Jang EH, Han YJ, Jang SE, Lee S. Association between diet quality and Sarcopenia in older adults: systematic review of prospective cohort studies. Life. 2021;11(8):811–28. CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Englund DA, Zhang X, Aversa Z, LeBrasseur NK. Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions. Mech Ageing Dev. 2021;200:111595. CrossRefPubMed Englund DA, Zhang X, Aversa Z, LeBrasseur NK. Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions. Mech Ageing Dev. 2021;200:111595. CrossRefPubMed
15.
Zurück zum Zitat Yin L, Li N, Jia W, et al. Skeletal muscle atrophy: from mechanisms to treatments. Pharmacol Res. 2021;172:105807. CrossRefPubMed Yin L, Li N, Jia W, et al. Skeletal muscle atrophy: from mechanisms to treatments. Pharmacol Res. 2021;172:105807. CrossRefPubMed
16.
Zurück zum Zitat Volpi E, Campbell WW, Dwyer JT, et al. Is the optimal level of protein intake for older adults greater than the recommended dietary allowance? J Gerontol A Biol Sci Med Sci. 2013;68:677–81. CrossRefPubMed Volpi E, Campbell WW, Dwyer JT, et al. Is the optimal level of protein intake for older adults greater than the recommended dietary allowance? J Gerontol A Biol Sci Med Sci. 2013;68:677–81. CrossRefPubMed
18.
Zurück zum Zitat McKendry J, Thomas ACQ, Phillips SM. Muscle mass loss in the older critically ill population: potential therapeutic strategies. Nutr Clin Pract. 2020;35:607–16. CrossRefPubMed McKendry J, Thomas ACQ, Phillips SM. Muscle mass loss in the older critically ill population: potential therapeutic strategies. Nutr Clin Pract. 2020;35:607–16. CrossRefPubMed
20.
24.
Zurück zum Zitat Wiedmer P, Jung T, Castro JP, et al. Sarcopenia—molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200. CrossRefPubMed Wiedmer P, Jung T, Castro JP, et al. Sarcopenia—molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200. CrossRefPubMed
25.
Zurück zum Zitat Riuzzi F, Sorci G, Arcuri C, et al. Cellular and molecular mechanisms of sarcopenia: the S100B perspective. J Cachexia Sarcopenia Muscle. 2018;9:1255–68. CrossRefPubMedPubMedCentral Riuzzi F, Sorci G, Arcuri C, et al. Cellular and molecular mechanisms of sarcopenia: the S100B perspective. J Cachexia Sarcopenia Muscle. 2018;9:1255–68. CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Vicenti G, Bortone I, Bizzoca D, et al. Bridging the gap between serum biomarkers and biomechanical tests in musculoskeletal ageing. J Biol Regul Homeost Agents. 2020;34:263–74. Congress of the Italian Orthopaedic Research Society. PubMed Vicenti G, Bortone I, Bizzoca D, et al. Bridging the gap between serum biomarkers and biomechanical tests in musculoskeletal ageing. J Biol Regul Homeost Agents. 2020;34:263–74. Congress of the Italian Orthopaedic Research Society. PubMed
27.
Zurück zum Zitat Bischoff-Ferrari HA. Vitamin D in geriatric patients. Internist. 2020;61:535–40. CrossRef Bischoff-Ferrari HA. Vitamin D in geriatric patients. Internist. 2020;61:535–40. CrossRef
29.
Zurück zum Zitat Bulgakova SV, Treneva EV, Zakharova NO. Hypovitaminosis D in the elderly: relationship with sarcopenia and dementia (review of literature). Klin Lab Diagn. 2021;66:5–9. CrossRefPubMed Bulgakova SV, Treneva EV, Zakharova NO. Hypovitaminosis D in the elderly: relationship with sarcopenia and dementia (review of literature). Klin Lab Diagn. 2021;66:5–9. CrossRefPubMed
32.
Zurück zum Zitat Abiri B, Vafa M. Vitamin D and muscle Sarcopenia in aging. Methods Mol Biol. 2020;2138:29–47. CrossRefPubMed Abiri B, Vafa M. Vitamin D and muscle Sarcopenia in aging. Methods Mol Biol. 2020;2138:29–47. CrossRefPubMed
33.
Zurück zum Zitat Montenegro KR, Cruzat V, Carlessi R, Newsholme P. Mechanisms of vitamin D action in skeletal muscle. Nutr Res Rev. 2019;32:192–204. CrossRefPubMed Montenegro KR, Cruzat V, Carlessi R, Newsholme P. Mechanisms of vitamin D action in skeletal muscle. Nutr Res Rev. 2019;32:192–204. CrossRefPubMed
34.
Zurück zum Zitat Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531–2. CrossRefPubMed Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531–2. CrossRefPubMed
35.
Zurück zum Zitat Drey M, Ferrari U, Schraml M, et al. German version of SARC-F: translation, adaption, and validation. J Am Med Dir Assoc. 2020;21:747–751.e1. CrossRefPubMed Drey M, Ferrari U, Schraml M, et al. German version of SARC-F: translation, adaption, and validation. J Am Med Dir Assoc. 2020;21:747–751.e1. CrossRefPubMed
36.
Zurück zum Zitat Shardell M, Semba RD, Kalyani RR, Hicks GE, Bandinelli S, Ferrucci L. Serum 25-Hydroxyvitamin D, plasma Klotho, and lower-extremity physical performance among older adults: findings from the inCHIANTI study. J Gerontol A Biol Sci Med Sci. 2015;70:1156–62. CrossRefPubMedPubMedCentral Shardell M, Semba RD, Kalyani RR, Hicks GE, Bandinelli S, Ferrucci L. Serum 25-Hydroxyvitamin D, plasma Klotho, and lower-extremity physical performance among older adults: findings from the inCHIANTI study. J Gerontol A Biol Sci Med Sci. 2015;70:1156–62. CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Shardell M, Cappola AR, Guralnik JM, et al. Sex-specific 25-hydroxyvitamin D threshold concentrations for functional outcomes in older adults: PRoject on Optimal VItamin D in Older adults (PROVIDO). Am J Clin Nutr. 2021;114:16–28. CrossRefPubMedPubMedCentral Shardell M, Cappola AR, Guralnik JM, et al. Sex-specific 25-hydroxyvitamin D threshold concentrations for functional outcomes in older adults: PRoject on Optimal VItamin D in Older adults (PROVIDO). Am J Clin Nutr. 2021;114:16–28. CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Wilson D, Jackson T, Sapey E, Lord JM. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017;36:1–10. CrossRefPubMed Wilson D, Jackson T, Sapey E, Lord JM. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017;36:1–10. CrossRefPubMed
44.
Zurück zum Zitat Pan L, Xie W, Fu X, et al. Inflammation and sarcopenia: a focus on circulating inflammatory cytokines. Exp Gerontol. 2021;154:111544. CrossRefPubMed Pan L, Xie W, Fu X, et al. Inflammation and sarcopenia: a focus on circulating inflammatory cytokines. Exp Gerontol. 2021;154:111544. CrossRefPubMed
45.
Zurück zum Zitat Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine. 2019;49:381–8. CrossRefPubMedPubMedCentral Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine. 2019;49:381–8. CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99:427–511. CrossRefPubMed Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99:427–511. CrossRefPubMed
48.
Zurück zum Zitat Santos-Eggimann B, Cuénoud P, Spagnoli J, Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009;64:675–81. CrossRefPubMed Santos-Eggimann B, Cuénoud P, Spagnoli J, Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009;64:675–81. CrossRefPubMed
49.
Zurück zum Zitat Reiss J, Iglseder B, Alzner R, et al. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing. 2019;48:719–24. CrossRefPubMed Reiss J, Iglseder B, Alzner R, et al. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing. 2019;48:719–24. CrossRefPubMed
50.
Zurück zum Zitat Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48:48–56. CrossRefPubMed Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48:48–56. CrossRefPubMed
51.
Zurück zum Zitat Papadopoulou SK, Tsintavis P, Potsaki P, Papandreou D. Differences in the prevalence of Sarcopenia in community-dwelling, nursing home and hospitalized individuals. A systematic review and meta-analysis. J Nutr Health Aging. 2020;24:83–90. CrossRefPubMed Papadopoulou SK, Tsintavis P, Potsaki P, Papandreou D. Differences in the prevalence of Sarcopenia in community-dwelling, nursing home and hospitalized individuals. A systematic review and meta-analysis. J Nutr Health Aging. 2020;24:83–90. CrossRefPubMed
52.
Zurück zum Zitat Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60. CrossRefPubMed Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60. CrossRefPubMed
53.
Zurück zum Zitat Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61:1059–64. CrossRefPubMed Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61:1059–64. CrossRefPubMed
54.
Zurück zum Zitat Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am Epidemiol Rev. 1998;147:755–63. CrossRef Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am Epidemiol Rev. 1998;147:755–63. CrossRef
55.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889–96 CrossRefPubMed Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889–96 CrossRefPubMed
57.
Zurück zum Zitat Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “”nutrition in geriatrics“. Clin Nutr. 2010;29:154–9. CrossRefPubMed Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “”nutrition in geriatrics“. Clin Nutr. 2010;29:154–9. CrossRefPubMed
58.
Zurück zum Zitat Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2009;64:377–84. CrossRefPubMed Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2009;64:377–84. CrossRefPubMed
59.
Zurück zum Zitat Xia L, Zhao R, Wan Q, et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9:7964–78. CrossRefPubMedPubMedCentral Xia L, Zhao R, Wan Q, et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9:7964–78. CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. CrossRefPubMed Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. CrossRefPubMed
61.
Zurück zum Zitat Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J cachexia sarcopenia muscle. 2018;9:269–78. CrossRefPubMedPubMedCentral Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J cachexia sarcopenia muscle. 2018;9:269–78. CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. CrossRefPubMed Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. CrossRefPubMed
63.
Zurück zum Zitat Chen LK, Woo J, Assantachai P, et al. Asian working group for Sarcopenia: 2019 consensus update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300–307.e2. CrossRefPubMed Chen LK, Woo J, Assantachai P, et al. Asian working group for Sarcopenia: 2019 consensus update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300–307.e2. CrossRefPubMed
65.
Zurück zum Zitat Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC. Nutrition, frailty, and sarcopenia. Aging Clin Exp Res. 2017;29:43–8. CrossRefPubMed Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC. Nutrition, frailty, and sarcopenia. Aging Clin Exp Res. 2017;29:43–8. CrossRefPubMed
66.
Zurück zum Zitat Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for Sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22:1148–61. CrossRefPubMed Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for Sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22:1148–61. CrossRefPubMed
67.
Zurück zum Zitat Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14:542–59. CrossRefPubMed Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14:542–59. CrossRefPubMed
68.
Zurück zum Zitat Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. CrossRefPubMedPubMedCentral Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. CrossRefPubMedPubMedCentral
69.
Zurück zum Zitat Beaudart C, Buckinx F, Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99:4336–45. CrossRefPubMed Beaudart C, Buckinx F, Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99:4336–45. CrossRefPubMed
71.
Zurück zum Zitat Kim JW, Kim R, Choi H, Lee SJ, Bae GU. Understanding of sarcopenia: from definition to therapeutic strategies. Arch Pharm Res. 2021;44:876–89. CrossRefPubMed Kim JW, Kim R, Choi H, Lee SJ, Bae GU. Understanding of sarcopenia: from definition to therapeutic strategies. Arch Pharm Res. 2021;44:876–89. CrossRefPubMed
Metadaten
Titel
Sarcopenia—a geriatric pandemic
A narrative review
verfasst von
Marcus Köller
Publikationsdatum
13.04.2022
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-022-00927-0